Vanda Pharmaceuticals Inc. Stock Chart

Vanda Pharmaceuticals Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Vanda Pharmaceuticals Inc.

LSE
Market Cap
$320.85M
Shares Out.
59.09M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

www.vandapharma.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0LKB.GB (0LKB.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart